APx Acquisition Corp. I
Status: Live Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $172.50M |
|---|---|
| IPO Date | Dec 7, 2021 |
| CEO | Kyle P. Bransfield |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 3 + 3 + 3 + 12 + 12 |
| IPO Sector | General ▶ |
| IPO Geography | LatAm |
| Target Company | OmnigenicsAI Corp |
| Deal Announced | Mar 26, 2024 |
| Deal Size, $M | $300.00M |
| Deal Sector | Healthcare |
| Deal Geography | LatAm |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Dec 4, 2024 |
APXIF
APXIU
APXIW
| Price | $11.90 |
|---|---|
| Last closing price | $11.90 |
| H/L, today | $11.90 / $11.90 |
| Volume, today | 1 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.